HeartBeam, Inc. (BEAT) stock
BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW
$0.55+0.01 (+2.06%)
Close on Oct 30, 2026Market cap $659.29KP/E –Yield –
HeartBeam EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
HeartBeam's EPS for the twelve months ending Jun 30, 2026 was -$0.52. For fiscal 2025 it was -$0.62. The highest annual figure on record is -$0.29 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.62 | – |
| FY2024 | Dec 31, 2024 | -$0.73 | – |
| FY2023 | Dec 31, 2023 | -$0.72 | – |
| FY2022 | Dec 31, 2022 | -$1.59 | – |
| FY2021 | Dec 31, 2021 | -$1.03 | – |
| FY2020 | Dec 31, 2020 | -$0.29 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.10 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.12 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.15 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.15 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.15 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.18 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.18 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.19 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.19 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.17 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.13 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.16 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.50 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.44 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.44 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.43 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.27 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.35 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.32 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.26 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.06 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.09 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.09 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics